Literature DB >> 21731836

A case of hypomania induced by lamotrigine augmentation.

Randy A Sansone1, Lori A Sansone.   

Abstract

Entities:  

Year:  2011        PMID： 21731836      PMCID： PMC3121208          DOI： 10.4088/PCC.10l01064

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  11 in total

1.  Hypomania induced by adjunctive lamotrigine.

Authors:  Howard C Margolese; Linda Beauclair; Nadia Szkrumelak; Guy Chouinard
Journal:  Am J Psychiatry       Date:  2003-01       Impact factor: 18.112

2.  Adjunctive lamotrigine as a possible mania inducer in bipolar patients.

Authors:  Sergey Raskin; Alexander Teitelbaum; Josef Zislin; Rimona Durst
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

3.  Hypomania with topiramate.

Authors:  Marcia Kaplan
Journal:  J Clin Psychopharmacol       Date:  2005-04       Impact factor: 3.153

4.  Hypomania induced by gabapentin.

Authors:  A Hauck; S Bhaumik
Journal:  Br J Psychiatry       Date:  1995-10       Impact factor: 9.319

5.  Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression.

Authors:  Ayal Schaffer; Pamela Zuker; Anthony Levitt
Journal:  J Affect Disord       Date:  2006-07-03       Impact factor: 4.839

6.  Hypomania induced by gabapentin.

Authors:  C Short; L Cooke
Journal:  Br J Psychiatry       Date:  1995-05       Impact factor: 9.319

7.  An open prospective study of zonisamide in acute bipolar depression.

Authors:  S Nassir Ghaemi; Benjamin Zablotsky; Megan M Filkowski; Robert T Dunn; Tamara B Pardo; Emily Isenstein; Claudia F Baldassano
Journal:  J Clin Psychopharmacol       Date:  2006-08       Impact factor: 3.153

8.  Divalproex in the treatment of bipolar depression: a placebo-controlled study.

Authors:  Lori L Davis; Al Bartolucci; Frederick Petty
Journal:  J Affect Disord       Date:  2005-04       Impact factor: 4.839

9.  A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.

Authors:  Susan L McElroy; Carlos A Zarate; John Cookson; Trisha Suppes; Russell F Huffman; Paul Greene; John Ascher
Journal:  J Clin Psychiatry       Date:  2004-02       Impact factor: 4.384

10.  Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.

Authors:  Marc L M van der Loos; Paul G H Mulder; Erwin G Th M Hartong; Marc B J Blom; Anton C Vergouwen; Herman J U E M de Keyzer; Peter J H Notten; Marijke L Luteijn; Manuela A Timmermans; Eduard Vieta; Willem A Nolen
Journal:  J Clin Psychiatry       Date:  2008-12-30       Impact factor: 4.384
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.